Cargando…

Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine

The anti-metabolite chemotherapeutic, gemcitabine is relatively effective for a spectrum of neoplastic conditions that include various forms of leukemia and adenocarcinoma/carcinoma. Rapid systemic deamination of gemcitabine accounts for a brief plasma half-life but its sustained administration is o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coyne, C. P., Jones, Toni, Bear, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376018/ https://www.ncbi.nlm.nih.gov/pubmed/25821636 http://dx.doi.org/10.4236/jct.2015.61009

Ejemplares similares

Anti-Neoplastic Cytotoxicity of Gemcitabine-(C(4)-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C(3)-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole
por: Coyne, CP, et al.
Publicado: (2014)

L‐Se‐methylselenocysteine sensitizes lung carcinoma to chemotherapy
por: Ma, Jia, et al.
Publicado: (2021)

Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferase
por: Ellis, Danielle R, et al.
Publicado: (2004)

Anti-Neoplastic Cytotoxicity of Gemcitabine-(C(4)-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3)
por: Coyne, CP, et al.
Publicado: (2013)

Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
por: Unni, Emmanual, et al.
Publicado: (2004)

Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients
por: Yue, Taohua, et al.
Publicado: (2023)

Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro
por: Unni, Emmanual, et al.
Publicado: (2005)

A Novel Assay Method to Determine the β-Elimination of Se-Methylselenocysteine to Monomethylselenol by Kynurenine Aminotransferase 1
por: Selvam, Arun Kumar, et al.
Publicado: (2020)

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models
por: Cao, S, et al.
Publicado: (2014)

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime(®)) and the recombinant Leish-110f(®) + MPL-SE(®) vaccine to treat canine visceral leishmaniasis
por: Miret, Jorge, et al.
Publicado: (2008)

Se-Methylselenocysteine Inhibits Apoptosis Induced by Clusterin Knockdown in Neuroblastoma N2a and SH-SY5Y Cell Lines
por: Wang, Chao, et al.
Publicado: (2014)

A Novel mRNA-Mediated and MicroRNA-Guided Approach to Specifically Eradicate Drug-Resistant Hepatocellular Carcinoma Cell Lines by Se-Methylselenocysteine
por: Selvam, Arun Kumar, et al.
Publicado: (2021)

The Effect of Methylselenocysteine and Sodium Selenite Treatment on microRNA Expression in Liver Cancer Cell Lines
por: Lendvai, Gábor, et al.
Publicado: (2020)

Optimized methyl donor and reduced precursor degradation pathway for seleno-methylselenocysteine production in Bacillus subtilis
por: Yin, Xian, et al.
Publicado: (2023)

The Toll-Like Receptor 2 agonist PEG-Pam(2)Cys as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites
por: Ernest, Medard, et al.
Publicado: (2018)

Gemcitabine‐(5′‐phosphoramidate)‐[anti‐IGF‐1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)
por: Coyne, Cody P., et al.
Publicado: (2016)

Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors
por: Qu, Lingzhi, et al.
Publicado: (2022)

A Rational Combination of Cyclocarya paliurus Triterpene Acid Complex (TAC) and Se-Methylselenocysteine (MSC) Improves Glucose and Lipid Metabolism via the PI3K/Akt/GSK3β Pathway
por: Bai, Xichen, et al.
Publicado: (2023)

Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway
por: Ding, Jun, et al.
Publicado: (2021)

Enhancement of NAD(+)-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells
por: Fang, Mingzhu, et al.
Publicado: (2015)

Programmable dynamic covalent nanoparticle building blocks with complementary reactivity
por: Marro, Nicolas, et al.
Publicado: (2019)

Algorithmic Modeling Quantifies the Complementary Contribution of Metabolic Inhibitions to Gemcitabine Efficacy
por: Kahramanoğullari, Ozan, et al.
Publicado: (2012)

Benzene Tetraamide: A Covalent Supramolecular Dual Motif in Dynamic Covalent Polymer Networks
por: Zhang, Huiyi, et al.
Publicado: (2023)

Dual recombinase action in the normal and neoplastic mammary gland epithelium
por: Rädler, Patrick D., et al.
Publicado: (2021)

Gemcitabine-induced skin necrosis
por: Haydock, Maria Monica, et al.
Publicado: (2018)

Development and Characterization of Nanoparticles for the Delivery of Gemcitabine Hydrochloride
por: Khaira, Rekha, et al.
Publicado: (2014)

Covalent binding of reactive estrogen metabolites to microtubular protein as a possible mechanism of aneuploidy induction and neoplastic cell transformation.
por: Epe, B, et al.
Publicado: (1990)

Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies
por: Yildiz, Isil Z, et al.
Publicado: (2009)

Simultaneous complementary idiotypic responses: absence of reciprocal regulation
por: Rowley, DA, et al.
Publicado: (1978)

Controlling hydrogel properties by tuning non-covalent interactions in a charge complementary multicomponent system
por: Panja, Santanu, et al.
Publicado: (2021)

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
por: Blackburn, Christopher, et al.
Publicado: (2010)

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
por: Blackburn, C., et al.
Publicado: (2010)

Dual deep modeling: multi-level modeling with dual potencies and its formalization in F-Logic
por: Neumayr, Bernd, et al.
Publicado: (2016)

Simultaneous Visualization of Covalent and Noncovalent Interactions Using Regions of Density Overlap
por: de Silva, Piotr, et al.
Publicado: (2014)

Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells
por: Sood, Nimil, et al.
Publicado: (2013)

Delivery of Gemcitabine Prodrugs Employing Mesoporous Silica Nanoparticles
por: Malfanti, Alessio, et al.
Publicado: (2016)

Complementary effects of Orthosiphon stamineus standardized ethanolic extract and rosmarinic acid in combination with gemcitabine on pancreatic cancer
por: Yehya, Ashwaq H.S., et al.
Publicado: (2021)

Covalent inorganic complexes enabled zinc blende to wurtzite phase changes in CdSe nanoplatelets
por: Kong, Xinke, et al.
Publicado: (2023)

Development of a C3c-based ELISA method for the determination of anti-complementary potency of Bupleurum polysaccharides
por: Wu, Mulu, et al.
Publicado: (2015)

Nanoparticle carrier co-delivery of complementary antibiofilm drugs abrogates dual species cariogenic biofilm formation in vitro
por: Roncari Rocha, Guilherme, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9qsb2p5caa14a1e2sbt6jip5eo